Geiger, Martina http://orcid.org/0000-0002-4747-6394
Stubenrauch, Kay-Gunnar
Sam, Johannes http://orcid.org/0000-0002-7455-0609
Richter, Wolfgang F. http://orcid.org/0000-0002-8094-8605
Jordan, Gregor
Eckmann, Jan
Hage, Carina http://orcid.org/0000-0002-5352-0742
Nicolini, Valeria
Freimoser-Grundschober, Anne http://orcid.org/0000-0001-5715-3639
Ritter, Mirko
Lauer, Matthias E. http://orcid.org/0000-0003-3252-8718
Stahlberg, Henning http://orcid.org/0000-0002-1185-4592
Ringler, Philippe
Patel, Jigar
Sullivan, Eric
Grau-Richards, Sandra
Endres, Stefan
Kobold, Sebastian http://orcid.org/0000-0002-5612-4673
Umaña, Pablo
Brünker, Peter
Klein, Christian http://orcid.org/0000-0001-7594-7280
Article History
Received: 25 January 2018
Accepted: 29 May 2020
First Online: 24 June 2020
Competing interests
: The authors declare the following competing interests. Parts of this work have been performed for the doctoral thesis of M.G. associated to the international doctoral program “i-Target” at the Ludwig-Maximilians-Universität München. M.G., K.-G.S., A.F.-G., M.R., M.E.L., J.S., J.E., C.H., W.F.R., G.J., V.N., P.U., P.B. and C.K. are employees of Roche. J.P. and E.S. are employees and hold ownership in Nimble Therapeutics. J.P. and E.S. own Nimble Therapeutics stock. C.K., P.B., A.F.-G., P.U., K.-G.S., M.G., E.S., J.P. are inventors in patent applications related to this work. C.K., P.U., M.G., P.B., W.F.R., M.R., G.J., S.G.R., J.S., A.F.-G. own Roche stock.